OR WAIT null SECS
© 2021 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
© 2021 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
CAPSTONE HEALTH SERVICES FOUNDATION PC
850 5TH AVE E
July 29, 2021
FDA approval means that pharmacists can swap biosimilar Semglee, an insulin product, for brand-name Lantus, although state-level pharmacy rules may apply.
July 14, 2021
Research note from SVB Leerink says revenue erosion once biosimilars hit the market in 2023 may be more gradual than some prior predictions.
July 01, 2021
April 26, 2021
Program could be easily implemented at tribal clinics, says lead author.